Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ResMed Inc. is preparing for a significant sale of its common stock, with Michael Farrell, a company officer and director, planning to sell 14,683 shares. The sale, which is planned for November 7, 2024, is expected to generate an aggregate market value of approximately $3.6 million. This move follows previous sales in August and September, highlighting active trading interest in ResMed’s shares.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
